(Q53027312)
Statements
A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer (English)
DuBrow R
1 reference
J. L. Abbruzzese
C. F. Gholson
K. Daugherty
E. Larson
R. DuBrow
R. Berlin
1 January 1992
1 reference
1 reference
7
1 reference
2
1 reference
165-171
1 reference
Identifiers
1 reference